KLK10

KLK10

Target · Serine protease

KLK10 Kallikrein related peptidase 10 · Kallikrein-10

KLK10 (kallikrein related peptidase 10, also known as NES1 or PRSSL1) is a secreted serine protease of the kallikrein subfamily. It has been linked to the suppression of tumorigenesis in breast and prostate cancers, and is studied as a candidate cancer biomarker. Browse Assay Genie's current range of KLK10 research reagents below, or read on for the biology behind the target.

Secreted proteinKallikrein serine proteaseTumour-suppressor role proposed
276 aa
Protein length
~30 kDa
Molecular weight
19q13.41
Gene locus
EC 3.4.21.-
Enzyme class
Target information

What is KLK10 (kallikrein related peptidase 10)?

KLK10 belongs to the kallikreins, a subgroup of serine proteases with diverse physiological functions. It sits in the peptidase S1 family, kallikrein subfamily, and carries the enzyme classification EC 3.4.21.-. The encoded protein is secreted. The UniProt annotation describes a tumour-suppressor role for NES1 in breast and prostate cancer, and the NCBI Gene summary states that the protein may play a role in suppressing tumorigenesis in these cancers.

The KLK10 gene is one of fifteen kallikrein subfamily members found in a cluster on chromosome 19. Alternate splicing of the gene produces multiple transcript variants, but all of them encode the same protein. Researchers working with the KLK10 protein therefore do not need to account for different protein isoforms arising from this splicing.

The gene is also known as NES1 and PRSSL1, and its earlier HGNC name was kallikrein 10. HGNC places it in the Kallikreins gene group. Growing evidence suggests that many kallikreins are implicated in carcinogenesis, and some have potential as novel biomarkers for cancer and other diseases. This makes KLK10 a frequent subject in studies of tumour biology and biomarker discovery, often alongside other members of the kallikrein family.

Breast cancer research

KLK10, also called NES1, has a described tumour-suppressor role in breast cancer, making it relevant to studies of tumorigenesis.

Prostate cancer research

The secreted KLK10 protein may play a role in suppressing tumorigenesis in prostate cancer.

Cancer biomarker studies

Many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers.

Kallikrein family biology

KLK10 is one of fifteen kallikrein serine proteases clustered on chromosome 19, useful for comparative family studies.

Background

KLK10 frequently asked questions

What does KLK10 do?

KLK10 is a secreted serine protease of the kallikrein subfamily. UniProt describes a tumour-suppressor role for NES1 in breast and prostate cancer, and NCBI Gene states it may play a role in suppressing tumorigenesis in these cancers.

What are the other names for KLK10?

KLK10 is also known as NES1 and PRSSL1. Its previous HGNC name was kallikrein 10, and the current name is kallikrein related peptidase 10. UniProt lists the protein as Kallikrein-10. Alternate splicing gives several transcript variants that encode the same protein.

How is KLK10 related to other kallikreins?

KLK10 is one of fifteen kallikrein subfamily members clustered on chromosome 19 and belongs to the peptidase S1 family. A rat ortholog, Klk10, is listed; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other kallikrein serine proteases from the chromosome 19 cluster that are studied alongside KLK10 in cancer and biomarker research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O43240; product specifications from Assay Genie datasheets.

KLK10 Product listing